Marca Figurativa depositada no INPI em 19/08/2020 por Sarepta Therapeutics, Inc., processo nº 501562218, nas classes 01, 05. Registro em vigor até 19/08/2030.
| Número do processo | 501562218 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Figurativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 19/08/2020 |
| Data da concessão | 23/11/2021 |
| Vigência até | 19/08/2030 |
| Titular | Sarepta Therapeutics, Inc. |
| CNPJ/CPF do titular | — |
| UF · País | — · US |
Chemical compounds and additives for use in pharmaceutical research; chemical compounds and additives for use in the manufacture of pharmaceuticals; diagnostic reagents for research use.;
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; gene therapy products for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501562218 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas4 despacho(s) publicado(s) na Revista da Propriedade Industrial.
1.13.1 Esferas armilares, planetários, órbitas astronômicas, modelos atômicos, modelos moleculares1.13.15 Modelos atômicos, modelos moleculares, representações de células humanas, animais ou vegetais29.1.12 Duas cores predominantes